WallStreetZenWallStreetZen

NASDAQ: LUMO
Lumos Pharma Inc Stock

$2.20-0.10 (-4.35%)
Updated Jun 18, 2024
LUMO Price
$2.20
Fair Value Price
N/A
Market Cap
$17.86M
52 Week Low
$2.01
52 Week High
$4.55
P/E
-0.48x
P/B
1.02x
P/S
14.99x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.53M
Earnings
-$37.13M
Gross Margin
100%
Operating Margin
-2,436.59%
Profit Margin
-2,434.7%
Debt to Equity
0.61
Operating Cash Flow
-$35M
Beta
0.72
Next Earnings
Aug 7, 2024
Ex-Dividend
N/A
Next Dividend
N/A

LUMO Overview

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare endocrine disorders. The company is headquartered in Austin, Texas.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how LUMO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

LUMO is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
LUMO is good value based on its book value relative to its share price (1.02x), compared to the US Biotechnology industry average (6.12x)
P/B vs Industry Valuation
LUMO is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more LUMO due diligence checks available for Premium users.

Be the first to know about important LUMO news, forecast changes, insider trades & much more!

LUMO News

Valuation

LUMO price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.48x
Industry
-7.59x
Market
31.44x

LUMO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.02x
Industry
6.12x
LUMO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

LUMO's financial health

Profit margin

Revenue
$165.0k
Net Income
-$10.4M
Profit Margin
-6,327.9%
LUMO's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
LUMO's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$28.1M
Liabilities
$10.6M
Debt to equity
0.61
LUMO's short-term assets ($27.54M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
LUMO's short-term assets ($27.54M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
LUMO's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
LUMO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$12.9M
Investing
$1.0M
Financing
-$5.0k
LUMO's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

LUMO vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
LUMO$17.86M-4.35%-0.48x1.02x
VINC$17.72M-7.12%-0.34x-28.49x
PMCB$17.69M-5.43%-1.74x0.56x
APLM$18.35M+6.77%-0.09x0.44x
ITRM$18.54M-0.88%-0.42x-3.01x

Lumos Pharma Stock FAQ

What is Lumos Pharma's quote symbol?

(NASDAQ: LUMO) Lumos Pharma trades on the NASDAQ under the ticker symbol LUMO. Lumos Pharma stock quotes can also be displayed as NASDAQ: LUMO.

If you're new to stock investing, here's how to buy Lumos Pharma stock.

What is the 52 week high and low for Lumos Pharma (NASDAQ: LUMO)?

(NASDAQ: LUMO) Lumos Pharma's 52-week high was $4.55, and its 52-week low was $2.01. It is currently -51.65% from its 52-week high and 9.45% from its 52-week low.

How much is Lumos Pharma stock worth today?

(NASDAQ: LUMO) Lumos Pharma currently has 8,116,488 outstanding shares. With Lumos Pharma stock trading at $2.20 per share, the total value of Lumos Pharma stock (market capitalization) is $17.86M.

Lumos Pharma stock was originally listed at a price of $63.72 in Nov 11, 2011. If you had invested in Lumos Pharma stock at $63.72, your return over the last 12 years would have been -96.55%, for an annualized return of -24.46% (not including any dividends or dividend reinvestments).

How much is Lumos Pharma's stock price per share?

(NASDAQ: LUMO) Lumos Pharma stock price per share is $2.20 today (as of Jun 18, 2024).

What is Lumos Pharma's Market Cap?

(NASDAQ: LUMO) Lumos Pharma's market cap is $17.86M, as of Jun 19, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Lumos Pharma's market cap is calculated by multiplying LUMO's current stock price of $2.20 by LUMO's total outstanding shares of 8,116,488.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.